Published in Proc Natl Acad Sci U S A on February 14, 2005
Integrating pathway analysis and genetics of gene expression for genome-wide association studies. Am J Hum Genet (2010) 3.63
The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes (2008) 2.77
Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol (2009) 2.63
Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse. Gut (2008) 2.30
The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol (2011) 2.26
Alterations in intestinal permeability. Gut (2006) 2.17
Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients (2012) 2.10
Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology (2008) 1.98
Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med (2013) 1.71
Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms. Ann N Y Acad Sci (2009) 1.39
Intestinal permeability defects: is it time to treat? Clin Gastroenterol Hepatol (2013) 1.21
Sensitization to gliadin induces moderate enteropathy and insulitis in nonobese diabetic-DQ8 mice. J Immunol (2011) 1.12
Restoration of impaired intestinal barrier function by the hydrolysed casein diet contributes to the prevention of type 1 diabetes in the diabetes-prone BioBreeding rat. Diabetologia (2010) 1.06
Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease. Diabetologia (2012) 1.04
Diabetes-specific HLA-DR-restricted proinflammatory T-cell response to wheat polypeptides in tissue transglutaminase antibody-negative patients with type 1 diabetes. Diabetes (2009) 1.02
An exploration of Glo-3A antibody levels in children at increased risk for type 1 diabetes mellitus. Pediatr Diabetes (2009) 1.00
Zonulin, regulation of tight junctions, and autoimmune diseases. Ann N Y Acad Sci (2012) 1.00
Can exposure to environmental chemicals increase the risk of diabetes type 1 development? Biomed Res Int (2015) 0.99
Intestinal permeability and its regulation by zonulin: diagnostic and therapeutic implications. Clin Gastroenterol Hepatol (2012) 0.98
Zinc carnosine, a health food supplement that stabilises small bowel integrity and stimulates gut repair processes. Gut (2006) 0.98
New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics. Clin Infect Dis (2015) 0.97
Dietary gluten and the development of type 1 diabetes. Diabetologia (2014) 0.94
The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease. Tissue Barriers (2013) 0.91
Noninflammatory gluten peptide analogs as biomarkers for celiac sprue. Chem Biol (2009) 0.91
Parallels between pathogens and gluten peptides in celiac sprue. PLoS Pathog (2008) 0.91
Gastrointestinal motility changes and myenteric plexus alterations in spontaneously diabetic biobreeding rats. J Neurogastroenterol Motil (2013) 0.91
Physiological, pathological, and therapeutic implications of zonulin-mediated intestinal barrier modulation: living life on the edge of the wall. Am J Pathol (2008) 0.89
Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells. PLoS One (2014) 0.87
Role of Corticotropin-releasing Factor in Gastrointestinal Permeability. J Neurogastroenterol Motil (2015) 0.87
The gut microbiota and Type 1 Diabetes. Clin Immunol (2015) 0.87
The potential utility of tight junction regulation in celiac disease: focus on larazotide acetate. Therap Adv Gastroenterol (2016) 0.86
Novel therapeutic/integrative approaches for celiac disease and dermatitis herpetiformis. Clin Dev Immunol (2012) 0.85
Protective Effects of Bifidobacterium on Intestinal Barrier Function in LPS-Induced Enterocyte Barrier Injury of Caco-2 Monolayers and in a Rat NEC Model. PLoS One (2016) 0.81
Activation of IFN-γ/STAT/IRF-1 in hepatic responses to Klebsiella pneumoniae infection. PLoS One (2013) 0.80
Anti-Saccharomyces cerevisiae antibodies in primary biliary cirrhosis. Dig Dis Sci (2007) 0.80
The role for gut permeability in the pathogenesis of type 1 diabetes - a solid or leaky concept? Pediatr Diabetes (2015) 0.80
Innate inflammation in type 1 diabetes. Transl Res (2015) 0.80
The Role of Gluten in Celiac Disease and Type 1 Diabetes. Nutrients (2015) 0.79
Celiac disease in patients with type 1 diabetes: a condition with distinct changes in intestinal immunity? Cell Mol Immunol (2011) 0.79
Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment. J Diabetes Res (2015) 0.79
Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers (2016) 0.78
The intestinal epithelial barrier: a therapeutic target? Nat Rev Gastroenterol Hepatol (2016) 0.78
Type 1 diabetes and gut microbiota: Friend or foe? Pharmacol Res (2015) 0.77
Permeability of rhynchophylline across human intestinal cell in vitro. Int J Clin Exp Pathol (2014) 0.77
The osteopontin transgenic mouse is a new model for Sjögren's syndrome. Clin Immunol (2015) 0.77
From intestinal permeability to dysmotility: the biobreeding rat as a model for functional gastrointestinal disorders. PLoS One (2014) 0.76
Role of the gastrointestinal ecosystem in the development of type 1 diabetes. Pediatr Diabetes (2015) 0.76
Regulation of intestinal permeability: The role of proteases. World J Gastroenterol (2017) 0.75
Acanthopanax senticosus polysaccharides-induced intestinal tight junction injury alleviation via inhibition of NF-κB/MLCK pathway in a mouse endotoxemia model. World J Gastroenterol (2017) 0.75
Homeostasis of the Gut Barrier and Potential Biomarkers. Am J Physiol Gastrointest Liver Physiol (2016) 0.75
Zonulin transgenic mice show altered gut permeability and increased morbidity/mortality in the DSS colitis model. Ann N Y Acad Sci (2017) 0.75
Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis. World J Gastroenterol (2016) 0.75
Type-specific human papillomavirus detection in cervical smears in Romania. APMIS (2010) 0.75
Gut immune deficits in LEW.1AR1-iddm rats partially overcome by feeding a diabetes-protective diet. Immunology (2015) 0.75
Leaky Gut As a Danger Signal for Autoimmune Diseases. Front Immunol (2017) 0.75
Zonulin: A Potential Marker of Intestine Injury in Newborns. Dis Markers (2017) 0.75
Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA (2003) 4.00
Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. Proc Natl Acad Sci U S A (1991) 3.43
Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA (2003) 3.39
Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet (2000) 2.82
Insulin secretion in type 1 diabetes. Diabetes (2004) 2.59
Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med (1983) 2.40
Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure. Gastroenterology (2002) 2.02
Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut (2003) 1.84
Gluten-free diet prevents diabetes in NOD mice. Diabetes Metab Res Rev (1999) 1.77
Intestinal permeation and gastrointestinal disease. J Clin Gastroenterol (2002) 1.68
Intestinal permeability in coeliac disease: the response to gluten withdrawal and single-dose gluten challenge. Gut (1982) 1.65
Celiac disease--how to handle a clinical chameleon. N Engl J Med (2003) 1.56
Increased gastrointestinal permeability is an early lesion in the spontaneously diabetic BB rat. Am J Physiol (1999) 1.49
Ultrastructural mucosal alterations and increased intestinal permeability in non-celiac, type I diabetic patients. Dig Liver Dis (2004) 1.47
In vitro-deranged intestinal immune response to gliadin in type 1 diabetes. Diabetes (2004) 1.41
Early feeding, antenatal glucocorticoids, and human milk decrease intestinal permeability in preterm infants. Pediatr Res (1998) 1.38
Zonula occludens toxin structure-function analysis. Identification of the fragment biologically active on tight junctions and of the zonulin receptor binding domain. J Biol Chem (2001) 1.25
The enterotoxic effect of zonula occludens toxin on rabbit small intestine involves the paracellular pathway. Gastroenterology (1997) 1.23
High frequency of coeliac disease in adult patients with type-I diabetes. Scand J Gastroenterol (1989) 1.17
Mucosal addressin is required for the development of diabetes in nonobese diabetic mice. J Immunol (1998) 1.13
Celiac disease-associated autoimmune endocrinopathies. Clin Diagn Lab Immunol (2001) 1.10
A predominant role of integrin alpha 4 in the spontaneous development of autoimmune diabetes in nonobese diabetic mice. Proc Natl Acad Sci U S A (1994) 1.10
Glutamate decarboxylase-reactive peripheral blood lymphocytes from patients with IDDM express gut-specific homing receptor alpha4beta7-integrin. Diabetes (1997) 1.08
Intraepithelial lymphocytes and coeliac disease: permanent changes in CD3-/CD7+ and T cell receptor gammadelta subsets studied by flow cytometry. Acta Paediatr (2000) 1.06
Membrane transporters. Eur J Pharm Sci (2000) 1.05
Intestinal permeability to mannitol and lactulose in children with type 1 diabetes with the HLA-DQB1*02 allele. Autoimmunity (2002) 1.04
Purification and preliminary characterization of the zonula occludens toxin receptor from human (CaCo2) and murine (IEC6) intestinal cell lines. FEMS Microbiol Lett (2001) 0.98
Proinflammatory effects of local abdominal irradiation on rat gastrointestinal tract. Dig Dis Sci (1989) 0.95
Do intestinal hyperpermeability and the related food antigens play a role in the progression of IgA nephropathy? I. Study of intestinal permeability. Am J Nephrol (1996) 0.92
Microbial-gut interactions in health and disease. Interactions between dendritic cells and bacteria in the regulation of intestinal immunity. Best Pract Res Clin Gastroenterol (2004) 0.91
Increased intestinal permeability as a cause of fluctuating postprandial blood glucose levels in Type 1 diabetic patients. Eur J Clin Invest (2003) 0.90
Deficiencies in gut NK cell number and function precede diabetes onset in BB rats. J Immunol (2004) 0.85
Gastroduodenal and intestinal permeability in primary biliary cirrhosis. Eur J Gastroenterol Hepatol (2003) 0.85
Nonneurologic manifestations of diabetic neuropathy. Mt Sinai J Med (1981) 0.80
Assessment of intestinal permeability and orocecal transit time in patients with systemic sclerosis: analysis of relationships with epidemiologic and clinical parameters. Rheumatol Int (2003) 0.79
Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med (2003) 7.80
The Oslo definitions for coeliac disease and related terms. Gut (2012) 5.76
Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr (2005) 5.34
Introduction of gluten, HLA status, and the risk of celiac disease in children. N Engl J Med (2014) 4.64
Specific oral tolerance induction in children with very severe cow's milk-induced reactions. J Allergy Clin Immunol (2007) 4.16
A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am J Clin Nutr (2007) 3.91
Detection of Celiac disease in primary care: a multicenter case-finding study in North America. Am J Gastroenterol (2007) 3.60
Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med (2012) 3.35
Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes (2006) 2.29
Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity. BMC Med (2011) 2.19
Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure. Gastroenterology (2002) 2.02
Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology (2008) 1.98
Natural history of celiac disease autoimmunity in a USA cohort followed since 1974. Ann Med (2010) 1.91
Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr Gastroenterol Nutr (2010) 1.82
Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scand J Gastroenterol (2006) 1.81
Differential mucosal IL-17 expression in two gliadin-induced disorders: gluten sensitivity and the autoimmune enteropathy celiac disease. Int Arch Allergy Immunol (2009) 1.78
Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants. PLoS One (2012) 1.74
Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders. Nutrients (2013) 1.74
Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci U S A (2009) 1.67
Might gluten traces in wheat substitutes pose a risk in patients with celiac disease? A population-based probabilistic approach to risk estimation. Am J Clin Nutr (2012) 1.56
Celiac disease--how to handle a clinical chameleon. N Engl J Med (2003) 1.56
Membrane-anchored serine protease matriptase regulates epithelial barrier formation and permeability in the intestine. Proc Natl Acad Sci U S A (2010) 1.52
Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent: role of the innate immune response in Celiac disease. J Immunol (2006) 1.51
Celiac disease. Curr Opin Gastroenterol (2008) 1.49
Tight junction modulation and its relationship to drug delivery. Adv Drug Deliv Rev (2006) 1.42
Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms. Ann N Y Acad Sci (2009) 1.39
Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population. Schizophr Bull (2009) 1.39
Analysis of proteinase-activated receptor 2 and TLR4 signal transduction: a novel paradigm for receptor cooperativity. J Biol Chem (2008) 1.38
World Gastroenterology Organisation global guidelines on celiac disease. J Clin Gastroenterol (2013) 1.29
Celiac disease diagnosis: simple rules are better than complicated algorithms. Am J Med (2010) 1.29
Infectious diarrhea in children: Working Group Report of the First World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr (2002) 1.25
VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for Celiac Sprue. Biochim Biophys Acta (2005) 1.19
The expression of caspases is enhanced in peripheral blood mononuclear cells of autism spectrum disorder patients. J Autism Dev Disord (2012) 1.19
Cutting edge: IL-1 controls the IL-23 response induced by gliadin, the etiologic agent in celiac disease. J Immunol (2008) 1.18
Microbiota and gut-liver axis: their influences on obesity and obesity-related liver disease. J Pediatr Gastroenterol Nutr (2013) 1.18
Looking for celiac disease: diagnostic accuracy of two rapid commercial assays. Am J Gastroenterol (2006) 1.14
Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency. Pediatr Res (2008) 1.14
Progress and pitfalls in Shigella vaccine research. Nat Rev Gastroenterol Hepatol (2013) 1.13
Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity. Psychiatr Q (2012) 1.13
Permeability, zonulin production, and enteropathy in dermatitis herpetiformis. Clin Gastroenterol Hepatol (2005) 1.11
Gastrointestinal conditions in children with autism spectrum disorder: developing a research agenda. Pediatrics (2012) 1.08
Deep sedation with propofol by nonanesthesiologists: a prospective pediatric experience. Arch Pediatr Adolesc Med (2003) 1.07
IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease. BMC Med Genet (2009) 1.06
Ganglioside reactive antibodies in the neuropathy associated with celiac disease. J Neuroimmunol (2002) 1.05
Cost-effective HLA typing with tagging SNPs predicts celiac disease risk haplotypes in the Finnish, Hungarian, and Italian populations. Immunogenetics (2009) 1.05
The new epidemiology of celiac disease. J Pediatr Gastroenterol Nutr (2014) 1.04
Digital radiology to improve the quality of care in countries with limited resources: a feasibility study from Angola. PLoS One (2013) 1.04
The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments. Eur J Biochem (2002) 1.03
IgE-mediated food allergy in children. Lancet (2013) 1.03
Anti transglutaminase antibodies cause ataxia in mice. PLoS One (2010) 1.02
Pediatric celiac disease. Curr Opin Pediatr (2009) 1.02
Trace gluten contamination may play a role in mucosal and clinical recovery in a subgroup of diet-adherent non-responsive celiac disease patients. BMC Gastroenterol (2013) 0.98
Presentation of celiac disease. Gastrointest Endosc Clin N Am (2012) 0.98
Zonula occludens toxin increases the permeability of molecular weight markers and chemotherapeutic agents across the bovine brain microvessel endothelial cells. J Pharm Sci (2003) 0.97
Characterizing monoclonal antibody epitopes by filtered gene fragment phage display. Biochem J (2005) 0.97
Monocytes differentiated with IL-15 support Th17 and Th1 responses to wheat gliadin: implications for celiac disease. Clin Immunol (2010) 0.96
Enteric pathogens and gut function: Role of cytokines and STATs. Gut Microbes (2010) 0.96
Increased prevalence of transglutaminase 6 antibodies in sera from schizophrenia patients. Schizophr Bull (2012) 0.95
Mechanisms of disease: protease functions in intestinal mucosal pathobiology. Nat Clin Pract Gastroenterol Hepatol (2007) 0.94
Matriptase protects against experimental colitis and promotes intestinal barrier recovery. Inflamm Bowel Dis (2011) 0.94
Regulatory T-cell function is impaired in celiac disease. Dig Dis Sci (2008) 0.93
Current concepts in the evaluation, diagnosis and management of acute infectious diarrhea. Curr Opin Pharmacol (2005) 0.93
Association analysis of the extended MHC region in celiac disease implicates multiple independent susceptibility loci. PLoS One (2012) 0.93
Intestinal infections and environmental enteropathy: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr (2004) 0.93
Association study of the IL18RAP locus in three European populations with coeliac disease. Hum Mol Genet (2008) 0.92
A gluten-free diet in people with schizophrenia and anti-tissue transglutaminase or anti-gliadin antibodies. Schizophr Res (2012) 0.92
Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders. J Autism Dev Disord (2013) 0.91
Helicobacter pylori-induced disruption of monolayer permeability and proinflammatory cytokine secretion in polarized human gastric epithelial cells. Infect Immun (2013) 0.90
Latest developments in the pathogenesis and treatment of celiac disease. J Pediatr (2006) 0.89
Secreted autotransporter toxin produced by a diffusely adhering Escherichia coli strain causes intestinal damage in animal model assays. FEMS Microbiol Lett (2005) 0.89
Dual sugar gut-permeability testing on blood drop in animal models. Clin Chim Acta (2005) 0.89
Zonulin as prehaptoglobin2 regulates lung permeability and activates the complement system. Am J Physiol Lung Cell Mol Physiol (2013) 0.89
Fasting increases tobramycin oral absorption in mice. Antimicrob Agents Chemother (2010) 0.89
Intestinal permeability in patients with chronic liver diseases: Its relationship with the aetiology and the entity of liver damage. Dig Liver Dis (2009) 0.89
Structural and functional alterations of the gastrointestinal tract following radiation-induced injury in the rhesus monkey. Dig Dis Sci (2002) 0.89
Is this really celiac disease? Pitfalls in diagnosis. Curr Gastroenterol Rep (2008) 0.88
Antibodies against food antigens in patients with autistic spectrum disorders. Biomed Res Int (2013) 0.88
Screening for celiac disease in family members: is follow-up testing necessary? Dig Dis Sci (2007) 0.88
RICH (rapidly involuting congenital hemangioma): not only a definition of wealth. J Pediatr (2012) 0.87
Relationship of HLA-DQ8 and severity of celiac disease: comparison of New York and Parisian cohorts. Clin Gastroenterol Hepatol (2004) 0.87
Zonula occludens toxin acts as an adjuvant through different mucosal routes and induces protective immune responses. Infect Immun (2003) 0.86
Identification of a novel immunomodulatory gliadin peptide that causes interleukin-8 release in a chemokine receptor CXCR3-dependent manner only in patients with coeliac disease. Immunology (2010) 0.86
Celiac disease as a cause of growth retardation in childhood. Curr Opin Pediatr (2004) 0.86
Profiling celiac disease antibody repertoire. Clin Immunol (2013) 0.86
Engineering of a multicellular organotypic model of the human intestinal mucosa. Gastroenterology (2011) 0.85